E-LIB Suche - Ergebnisse für: López Fauqued, Marta

1

37. Safety Profile of the Adjuvanted Recombinant Zoster Vac..:

Fauqued, Marta Lopez ; Co, Maribel Miranda ; Bastidas, Adriana...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S42-S43 , 2020

Link: https://doi.org/10.1093/..

2

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Su..:

Schwarz, Tino F ; Aggarwal, Naresh ; Moeckesch, Beate...
The Journal of Infectious Diseases. 216 (2017) 11 - p. 1352-1361 , 2017

Link: https://doi.org/10.1093/..

3

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Su..:

Schwarz, Tino F. ; Aggarwal, Naresh ; Moeckesch, Beate...
The Journal of Infectious Diseases. 216 (2017) 11 - p. 1352-1361 , 2017

Link: https://www.jstor.org/st..

4

Predicting the submission frequency of periodic safety upda..:

Gordillo-Marañón, María ; Candore, Gianmario ; López-Fauqued, Marta...
Frontiers in Medicine. 11 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

5

Understanding thrombosis with thrombocytopenia syndrome aft..:

Buoninfante, Alessandra ; Andeweg, Arno ; Baker, Alexander T....
npj Vaccines. 7 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

6

Safety Profile of the Adjuvanted Recombinant Zoster Vaccine..:

López-Fauqued, Marta ; Co-van der Mee, Maribel ; Bastidas, Adriana...
Drug Safety. 44 (2021) 7 - p. 811-823 , 2021

Link: https://doi.org/10.1007/..

7

Review of the initial post-marketing safety surveillance fo..:

Tavares-Da-Silva, Fernanda ; Co, Maribel Miranda ; Dessart, Christophe...
Vaccine. 38 (2020) 18 - p. 3489-3500 , 2020

Link: https://doi.org/10.1016/..

8

Immunogenicity and Safety of the Adjuvanted Recombinant Zos..:

Vink, Peter ; Ramon Torrell, Josep Maria ; Sanchez Fructuoso, Ana...
Clinical Infectious Diseases. , 2019

Link: https://doi.org/10.1093/..

9

Safety profile of the adjuvanted recombinant zoster vaccine..:

López-Fauqued, Marta ; Campora, Laura ; Delannois, Frédérique...
Vaccine. 37 (2019) 18 - p. 2482-2493 , 2019

Link: https://doi.org/10.1016/..

10

2776. Post-marketing Safety Surveillance for the Adjuvanted..:

Tavares-Da-Silva, Fernanda ; Miranda Co, Maribel ; Dessart, Cristophe...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S979-S980 , 2019

Link: https://doi.org/10.1093/..

11

Safety profile of the adjuvanted recombinant zoster vaccine..:

López Fauqued, Marta ; Campora, Laura ; Delannois, Frédérique...
Vaccine. , 2019

Link: https://ddd.uab.cat/reco..

12

2483. Twelve-Month Immunogenicity and Safety of an Adjuvant..:

Vink, Peter ; Torrell, Josep Maria Ramon ; Sanchez-Fructuoso, Ana I...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S744-S745 , 2018

Link: https://doi.org/10.1093/..

13

149. Immunogenicity, Safety, and Post-hoc Efficacy Assessme..:

Dagnew, Alemnew F ; Ilhan, Osman ; Lee, Won-Sik...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S9-S10 , 2018

Link: https://doi.org/10.1093/..

14

A randomized lot-to-lot immunogenicity consistency study of..:

Strezova, Ana ; Godeaux, Olivier ; Aggarwal, Naresh...
Vaccine. 35 (2017) 48 - p. 6700-6706 , 2017

Link: https://doi.org/10.1016/..

15

Results of a Safety Pooled Analysis of an Adjuvanted Herpes..:

López-Fauqued, Marta ; Campora, Laura ; Delannois, Frédérique...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S416-S416 , 2017

Link: https://doi.org/10.1093/..